RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
…
Rockwood Research

Corporate filings · Event Monitor · Free for all

← Back

Avalo Therapeutics, Inc.

AVTX

Pharmaceutical Preparations · SIC 2834 · CIK 0001534120

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.0M
Net Income
$(78.0M)
EPS (Basic)
$-5.84
Net Margin
-132642.4%
ROE
-94.2%
Total Equity
$83.0M
Shares Out
54M

Avalo Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 4 funds in our universe

FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$18.5M
0.1%
+50.8%
Vivo Capital
Vivo Capital
$5.1M
0.1%
NEW
Adage Capital Management
Adage Capital Management
$32.0M
0.0%
+102.5%
Baker Bros. Advisors
Baker Bros. Advisors
$10.2M
0.0%
NEW

Insider Transactions

Reading stored insider transactions…